CEP
PFE icon

Chicago Equity Partners’s Pfizer PFE Stock Holding History

Chicago Equity Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.5M Sell
48,605
-4,005
-8% -$136K 0.15% 203
2019
Q4 		$1.96M Sell
52,610
-13,202
-20% -$470K 0.11% 274
2019
Q3 		$2.24M Sell
65,812
-173,178
-72% -$6.3M 0.11% 289
2019
Q2 		$9.82M Sell
238,990
-150,064
-39% -$5.96M 0.44% 38
2019
Q1 		$15.7M Sell
389,054
-20,626
-5% -$826K 0.61% 22
2018
Q4 		$17M Sell
409,680
-30,667
-7% -$1.27M 0.68% 16
2018
Q3 		$18.4M Sell
440,347
-10,704
-2% -$412K 0.54% 31
2018
Q2 		$15.5M Sell
451,051
-113,310
-20% -$3.87M 0.48% 37
2018
Q1 		$19M Buy
564,361
+290,648
+106% +$9.99M 0.61% 21
2017
Q4 		$9.41M Buy
273,713
+7,220
+3% +$246K 0.29% 94
2017
Q3 		$9.03M Sell
266,493
-361,292
-58% -$11.6M 0.29% 86
2017
Q2 		$20M Sell
627,785
-343,266
-35% -$10.8M 0.54% 37
2017
Q1 		$31.5M Sell
971,051
-221,449
-19% -$6.98M 0.91% 16
2016
Q4 		$36.7M Sell
1,192,500
-304,796
-20% -$9.31M 0.98% 12
2016
Q3 		$48.1M Sell
1,497,296
-9,106
-0.6% -$304K 1.33% 9
2016
Q2 		$50.3M Sell
1,506,402
-104,456
-6% -$3.33M 1.47% 7
2016
Q1 		$45.3M Sell
1,610,858
-302,484
-16% -$8.64M 1.32% 9
2015
Q4 		$58.6M Buy
1,913,342
+376,468
+24% +$11.8M 1.56% 8
2015
Q3 		$45.8M Buy
1,536,874
+451,702
+42% +$14.5M 1.28% 8
2015
Q2 		$34.5M Sell
1,085,172
-59,512
-5% -$1.94M 0.94% 24
2015
Q1 		$37.8M Sell
1,144,684
-1,047,882
-48% -$33.3M 1.01% 22
2014
Q4 		$64.8M Sell
2,192,566
-207,952
-9% -$5.96M 1.74% 8
2014
Q3 		$67.3M Sell
2,400,518
-3,673
-0.2% -$103K 1.77% 9
2014
Q2 		$67.7M Buy
2,404,191
+28,100
+1% +$801K 1.79% 6
2014
Q1 		$72.4M Buy
2,376,091
+183,501
+8% +$5.47M 2% 3
2013
Q4 		$63.7M Buy
2,192,590
+1,931
+0.1% +$56.2K 1.91% 3
2013
Q3 		$59.7M Sell
2,190,659
-180,028
-8% -$4.9M 1.85% 3
2013
Q2 		$63M Buy
+2,370,687
New +$65.5M 1.96% 2

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Chicago Equity Partners's PFE Position: Q1 2020 in Review

Chicago Equity Partners reduced its Pfizer (PFE) stake by 7.6% in Q1 2020, selling an estimated $136K and leaving 48,605 shares worth $1.5M. The position accounts for 0.15% of the portfolio, ranked #203.

Chicago Equity Partners first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. The position peaked at $72.4M in Q1 2014. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Chicago Equity Partners held 48,605 shares of Pfizer worth $1.5M as of Q1 2020.
  • Chicago Equity Partners sold 4,005 Pfizer shares in Q1 2020, an estimated $136K.
  • Pfizer made up 0.15% of Chicago Equity Partners's portfolio in Q1 2020, its #203 holding.
  • Chicago Equity Partners first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • Chicago Equity Partners's Pfizer position peaked at $72.4M in Q1 2014.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.